DAMARIS PORTER: Open Payments
NPI 1245609072 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 21 payments from 13 companies in 2025. Trend: 2023 $497 · 2024 $409 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $64 |
| TerSera Therapeutics LLC | 3 | $62 |
| Lundbeck LLC | 2 | $52 |
| Janssen Biotech, Inc. | 1 | $45 |
| Lilly USA, LLC | 2 | $43 |
| Grifols USA, LLC | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 1 | $33 |
| Daiichi Sankyo Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $23 |
| Biogen, Inc. | 1 | $20 |
Products named: Quzyttir, VYEPTI, TREMFYA, KISUNLA, Gamunex-C, EVENITY, SAPHNELO, INJECTAFER.
Industry payments across TX — which companies pay providers there.
